Sign in
Taking people in United StatesNo phase

Mechanisms Underlying the Efficacy of Prolonged Exposure

Key facts

Who runs it
VA Boston Healthcare System
Where
Boston, United StatesSee the site
Trial code
Status
Recruiting
People taking part
50 people, planned
Started
1 Jan 2024
Expected to end
1 Jan 2027
Type of study
Interventional
Treatments tested
  • Prolonged Exposure Therapy for Posttraumatic Stress Disorder
Record updated
8 April 2025

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • a diagnosis of PTSD as defined by DSM-5 (as indicated by meeting diagnostic criteria on the CAPS-5)
  • interest in starting PE (as indicated during the informed consent process)
  • Veteran

Who cannot take part

  • Current participation in cognitive-behavioral therapy,
  • Previously received > 2 sessions of Prolonged Exposure, and
  • For participants who are currently prescribed psychotropic medication, they will be eligible for the study provided medication use has been stable for 2 months prior to enrollment and remains stable throughout participation
  • Current or past history of schizophrenic or other psychotic disorders,
  • Untreated Bipolar Disorder or a history of a manic/mixed episode within the last 6 months,
  • Current substance use disorder,
  • Severe traumatic brain injury,
  • Major neurological problems,
  • Active risk to self or others,
  • Having no memory of their traumatic event

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 90 years old?

This trial is currently available in United States.

  • VA Boston Healthcare SystemBoston, United StatesContact: Suzanne Pineles, PhDTaking people

About the trial

What the trial wants to find out

The primary objective of this research is to collect pilot data that demonstrates that proposed neural, psychophysiological and subjective markers measured before, during, and after treatment change over the course of Prolonged Exposure therapy (PE) for posttraumatic stress disorder (PTSD). The aims of the study are to: (1) examine theoretically informed mechanisms as pre-treatment predictors of PE treatment efficacy, (2) characterize how neural, psychophysiological, and subjective markers measured before, during, and after treatment change over the course of PE, and (3) examine proposed mechanisms of change as measures of PE treatment efficacy. This is a longitudinal study of predictors of exposure therapy efficacy that will be conducted within the context of a standard 10 session PE treatment trial, with independent multimodal assessment batteries administered at pre-treatment, mid-treatment, post-treatment, and at 1-month follow-up. This data will be used to support a future NIMH and/or VA grant submission.

The group in the trial

  • Prolonged Exposure Therapy for Posttraumatic Stress DisorderTreatment being tested

    15 participants who meet study inclusion/exclusion criteria will be individually administered a full course of PE during 10, 60 minute-sessions, with independent multimodal assessment batteries administered at pre-treatment, mid-treatment (post session 5), post-treatment, and a 1-month follow-up.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT05663151, who can take part
Record updated
8 April 2025